NLS Global report

Sound Bioventures has announced a new investment in NephroDI Therapeutics, a US-based, near-clinical stage pharmaceutical company focusing on concentration disorders of the kidney. In conjunction with this investment, Bibhash Mukhopadhyay, Managing Partner at Sound Bioventures, will join NephroDI’s Board of Directors. “At Sound Bioventures, we aim to back innovative companies working to address some of […]

The SciLifeLab board has appointed Professor Jan Ellenberg as the new Director. Alongside this role, Professor Ellenberg will also be appointed as a Professor at Karolinska Institutet and Affiliated Professor at Stockholm University and KTH Royal Institute of Technology. He succeeds Professor Olli Kallioniemi, who has served as SciLifeLab Director since 2015. Ellenberg is moving […]

The planned facility will be AstraZeneca’s first end-to-end antibody drug conjugates (ADC) production site, fully incorporating all steps of the manufacturing process at a commercial scale. “Singapore is one of the world’s most attractive countries for investment given its reputation for excellence in complex manufacturing, and I am excited for AstraZeneca to locate our USD […]

Karolinska Institutet’s president, Annika Östman Wernerson, and vice-president, Martin Bergö, have written an open letter to Sweden’s minister for foreign affairs and minister for education, calling on them to use all means available to increase the pressure on Iran to free Dr Djalali and other Swedish citizens. Eight years ago, on 25 April, Ahmadreza Djalali […]

After a positive initial safety evaluation, the pioneering STEM-PD (stem cell-based transplant for Parkinson’s disease) clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived from stem cells. A […]

The new partnership will support critical scientific R&D for global health and is focused on advancing solutions that are accessible and affordable to people in low- and middle-income countries. The three-year initiative was announced at the Novo Nordisk Foundation’s Global Science Summit in Denmark, where each organization committed USD 100 million, for a total of […]